Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC40H40N10O8S2 |
InChIKeyGRYRXFYWVDWPQY-UHFFFAOYSA-N |
CAS Registry2098487-75-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | DE | 25 Jan 2018 |